Himadri Speciality Chemical Ltd.
NSE: HSCLHimadri Speciality Chemical Ltd.: A 30-second snapshot
Himadri Speciality Chemicals (HSCL) is a Chemicals sector stock trading at ₹637.65, up 48.4% over the past 12 months and near its 52-week high. Trailing PE stands at 40.9 against a forward PE of 29.9, implying the market is pricing in significant earnings acceleration. The company carries a debt-to-equity ratio of 16.14, well above sector norms, while fundamental quality persistence metrics remain thin across the available historical record.
P/E
40.9
Forward P/E
29.9
ROE
+17.7%
Debt / Equity
16.14
Profit Margin
+16.1%
Div. Yield
+0.1%
5Y ROE > 15%
1/5
5Y FCF > 0
2/5
Quality
54/100
News
8 headlines · 6 positive · 0 negative
Himadri Speciality Chemicals aims to double profit by FY28 - The Hindu
The Hindu
Himadri Speciality Chemicals unveils growth roadmap, eyes expansion across high-value segments - ET Manufacturing
ET Manufacturing
Himadri reports ₹1,006 crore EBITDA, launches 200 MTPA anode facility - Manufacturing Today India
Manufacturing Today India
Himadri Speciality shares rally 13% to fresh record high after Q4 earnings, launch of new facility. Do you - The Economic Times
The Economic Times
Himadri Speciality Chemical Shares Jump Nearly 13% After Q4 Profit Boost - NDTV Profit
NDTV Profit
Recent context
- ·Q4 results reported in late April 2026 showed ₹1,006 crore EBITDA, accompanied by the launch of a 200 MTPA anode facility, triggering a reported 13% single-session price move to a then-record high.
- ·Management publicly guided for doubling profit by FY28 and outlined a growth roadmap across high-value segments including anode materials, as reported by The Hindu and ET Manufacturing in early May 2026.
- ·News flow across the 8 most recent articles is 6 positive, 2 neutral, and 0 negative; coverage is concentrated around the Q4 result event and FY28 guidance rather than diversified across operational milestones.
Strengths
- +ROE of 17.7% ranks 2nd among 6 sector peers with available data (peer median ROE range: 13.8–23.5%), and quality score of 64 ranks 2nd of 6 in the Chemicals peer group.
- +5-year revenue growth of 13.5% and 5-year earnings growth of 27.8% demonstrate compounding at the earnings line faster than revenue, consistent with margin expansion over the period.
- +Stock is positioned above both its 50-DMA (₹495.75) and 200-DMA (₹473.26), with the current price of ₹637.65 representing a 28.6% premium to the 50-DMA and a 34.7% premium to the 200-DMA.
- +PE of 40.9 ranks 3rd of 6 among sector peers (Pidilite at 59.7, Solar Industries at 101.0 are meaningfully higher), positioning HSCL as mid-range on valuation relative to larger specialty chemicals names.
Weaknesses
- −Debt-to-equity of 16.14 is a structural concern; in the non-financial Chemicals sector, this level of leverage leaves limited margin for error if earnings disappoint or credit conditions tighten.
- −Fundamental quality persistence is weak: ROE has been above 15% in only 1 of the available historical years, FCF has been positive in only 2 years, and the consistency score is 42 of 100 — recent profitability improvements have not yet demonstrated multi-year durability.
- −RSI of 80.19 reflects a deeply overbought reading following a 38.9% gain in 3 months; the nearest identified support levels (₹459.10, ₹457.25, ₹447.00) are 27–30% below the current price, with no resistance levels identified above current price.
- −Only 1 analyst is covering the stock, making the analyst rating of 3.0 (1–5 scale, lower = more constructive) statistically uninformative and leaving management forward guidance for profit doubling by FY28 without meaningful independent corroboration.
Open questions
- ?Given the debt-to-equity of 16.14, what is the interest coverage ratio and how sensitive is net profit to a 100–200 bps rise in borrowing costs?
- ?The forward PE of 29.9 versus trailing PE of 40.9 implies a meaningful step-up in earnings — what specific volume, pricing, or margin assumptions underlie the FY28 profit doubling guidance?
- ?ROE has been above 15% in only 1 of the available historical years despite 5-year earnings CAGR of 27.8% — does the earnings growth reflect genuine return improvement or a base effect from a low-profit starting point?
- ?Support levels identified are 27–30% below the current price with no resistance levels found above current price — how has the stock historically behaved in terms of drawdown following similarly sharp 3-month rallies?
Peer comparison: Chemicals
Ranks 2 of 6 on quality| Symbol | Name | P/E | ROE | Quality |
|---|---|---|---|---|
| HSCL | Himadri Speciality Chemical Ltd.You're viewing | 40.9 | +17.7% | 64 |
| Industry avg | across 5 peers | 53.3 | +17.6% | 44 |
| PIDILITIND | Pidilite Industries Ltd. | 59.7 | +23.5% | 66 |
| SOLARINDS | Solar Industries India Ltd. | 101.0 | — | 57 |
| SRF | SRF Ltd. | 45.1 | +13.8% | 41 |
| COROMANDEL | Coromandel International Ltd. | 28.1 | +15.6% | 30 |
| PIIND | PI Industries Ltd. | 32.4 | — | 25 |
Technical state
Current price
₹637.65
SMA 50
₹495.75
SMA 200
₹473.26
RSI (14)
80.2 (overbought)
From 52w high
-2.6%
1Y return
+48.4%
3M return
+38.9%
50-DMA
Above
200-DMA
Above
Algorithmic support levels
Risk flags
- highDebt-to-equity of 16.14 is substantially above typical Chemicals sector levels, indicating heavy leverage; debt trend is classified as flat with no deleveraging observed.
- highROE has exceeded 15% in only 1 of the available historical years, and FCF has been positive in only 2 of the available years — fundamental quality persistence (consistencyScore 42 of 100) is weak relative to the current PE of 40.9.
- mediumRSI of 80.19 places the stock in overbought territory; the stock is up 48.4% over 12 months and 38.9% over 3 months, with drawdown from 52-week high of just 2.6%, suggesting the recent run has been sharp and concentrated.
- lowAnalyst coverage is limited to 1 analyst, providing very thin institutional scrutiny for a stock trading at a PE of 40.9 with management guidance for doubling profit by FY28.
Cross-section contradictions
- Stock is up 48.4% over 12 months and trades within 2.6% of its 52-week high, yet fundamental persistence is weak: ROE has cleared 15% in only 1 historical year and FCF has been positive in only 2 years, with a consistencyScore of 42 of 100.
- News sentiment is 6 positive out of 8 articles and management is publicly guiding for profit doubling by FY28, but only 1 analyst covers the stock — the constructive narrative has minimal independent verification.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 24 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 12 May 2026 · rotates through NIFTY 500 every ~5 days